Tvardi Therapeutics
NASDAQ: TVRD
$0.81
+0.01
(+1.58%)
as on
Tvardi Therapeutics Stock Performance
as on November 3, 2026 at 2:16 pm IST
Day's Low
Day's High
$0.79$0.85
1.90%
Downside
5.55%
Upside
52 Week's Low
52 Week's High
$0.77$5.694.02%
Downside
606.57%
Upside
Tvardi Therapeutics share price movements today
- Previous Close
- $0.79
- Open
- $0.81
- Volume
- 503.5K
- Market Cap
- $10.6M
- Day's Low - High
- $0.79 - $0.85
- 52 Week Low - High
- $0.77 - $5.69
Tvardi Therapeutics Historical Returns
- 1 Month Return
- -29.97 %
- 3 Month Return
- -60.13 %
- 1 Year Return
- -82.14 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Tvardi Therapeutics Stock Fundamentals & Key Indicators
Check Tvardi Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.6M
EPS (TTM)
-2.79
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.28
Industry PE ratio
-3.13
PEG Ratio
0.01
EBITDA
-26.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-145.40%
Tvardi Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Tvardi Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $10.6M | NA | -0.28 | 0.00% | 0.00% | |
| Neutral | $88.5B | -36.16% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 192.56% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 47.41% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Tvardi Therapeutics Stock including INR - Dollar returns
The Tvardi Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Tvardi Therapeutics investment value today
Current value as on today
₹19,099
Returns
Returns from Tvardi Therapeutics Stock
Dollar Impact
₹1,243 (+1.24%)
Analyst Recommendation on Tvardi Therapeutics Stock
Based on 3 analysts
66.67%
Buy
0.00%
Hold
33.33%
Sell
Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Tvardi Therapeutics. Average target price of $6
Tvardi Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Tvardi Therapeutics.
Current Price
$0.8053
Analyzed by
3 Analysts
High
$10
Low
$3
Tvardi Therapeutics target price $0, a slight upside of 0% compared to current price of $0.8053. According to 3 analysts rating.
Indian Investors' Interest in Tvardi Therapeutics Stock
Search interest for Tvardi Therapeutics Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Tvardi Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Tvardi Therapeutics Annual Profit & Loss
All numbers in Millions USD
Tvardi Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Tvardi Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Tvardi Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 868.6%
NEGATIVE IMPACTPrice Dip
In the last 3 months, TVRD stock has moved down by -60.1%
About Tvardi Therapeutics
| Organisation | Tvardi Therapeutics |
| Headquarters | 3 Sugar Creek Center Boulevard, Sugar Land, TX, 77478, US |
| Industry | Biotechnology |
| CEO | Imran Alibhai |
Key Management of Tvardi Therapeutics
Name | Title |
|---|---|
Dr. Imran Alibhai Ph.D. | CEO & Director |
Mr. Dan Conn J.D., M.B.A. | CFO & Corporate Secretary |
Dr. John Kauh M.D. | Chief Medical Officer |
Dr. Jeffrey Larson DABT, Ph.D. | Senior Vice President of R&D |
Dr. Yixin Chen Ph.D. | Vice President of CMC |
Mr. David J. Tweardy M.D. | Co-Founder & Scientific Advisory Board Member |
Dr. Ronald A. DePinho M.D. | Co-Founder & Chairman of Scientific Advisory Board |
Dr. Michael T. Lewis Ph.D. | Co-Founder & Scientific Advisory Board Member |
Mr. Stephen O'Brien CPA | VP of Finance & Corporate Controller |
FAQs
What is Tvardi Therapeutics share price today?
Tvardi Therapeutics share price today is $0.81 as on at the close of the market. Tvardi Therapeutics share today touched a day high of $0.85 and a low of $0.79.
What is the 52 week high and 52 week low for Tvardi Therapeutics share?
Tvardi Therapeutics share touched a 52 week high of $5.69 on and a 52 week low of $0.77 on . Tvardi Therapeutics stock price today i.e. is closed at $0.81,which is 85.85% down from its 52 week high and 4.19% up from its 52 week low.
What is Tvardi Therapeutics's market capitalisation today?
Tvardi Therapeutics market capitalisation is $0.00T as on .
How to invest in Tvardi Therapeutics Stock (TVRD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Tvardi Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Tvardi Therapeutics Stock (TVRD) from India?
Indian investors can start investing in Tvardi Therapeutics (TVRD) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Tvardi Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Tvardi Therapeutics share’s latest price of $0.81 as on November 3, 2026 at 8:46 am IST, you will get 12.4177 shares of Tvardi Therapeutics. Learn more about
fractional shares .